A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)
Phase
1/2Span
107 weeksSponsor
Memorial Sloan Kettering Cancer CenterMontvale, New Jersey
Recruiting
A Study of a Weight Loss Intervention in People With Endometrial Cancer
Phase
1Span
106 weeksSponsor
Memorial Sloan Kettering Cancer CenterMontvale, New Jersey
Recruiting
A Study of Enasidenib in People With T-Cell Lymphoma
Phase
2Span
158 weeksSponsor
Memorial Sloan Kettering Cancer CenterMontvale, New Jersey
Recruiting
A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer
Phase
1Span
105 weeksSponsor
Memorial Sloan Kettering Cancer CenterMontvale, New Jersey
Recruiting
A Study of SER-155 to Treat Diarrhea in People on Immunotherapy
Phase
1Span
105 weeksSponsor
Memorial Sloan Kettering Cancer CenterMontvale, New Jersey
Recruiting
Acupuncture for People Experiencing Period Loss Due to Chemotherapy
Phase
2Span
105 weeksSponsor
Memorial Sloan Kettering Cancer CenterMontvale, New Jersey
Recruiting
A Study of Fluorescein Sodium in People Undergoing Vulvectomy for Extramammary Paget's Disease (EMPD)
Phase
2Span
108 weeksSponsor
Memorial Sloan Kettering Cancer CenterMontvale, New Jersey
Recruiting
A Study of Enfortumab Vedotin in People With Adenoid Cystic Carcinoma
Phase
2Span
105 weeksSponsor
Memorial Sloan Kettering Cancer CenterMontvale, New Jersey
Recruiting
A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)
Phase
2Span
108 weeksSponsor
Memorial Sloan Kettering Cancer CenterMontvale, New Jersey
Recruiting
A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis
Phase
1/2Span
160 weeksSponsor
Memorial Sloan Kettering Cancer CenterMontvale, New Jersey
Recruiting
1-10 of 266